Cost Of Revenue - S2Medical AB (publ) (STO:S2M) - Alpha Spread
S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.024 SEK Market Closed
Market Cap: 6.4m SEK
Have any thoughts about
S2Medical AB (publ)?
Write Note

S2Medical AB (publ)
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

S2Medical AB (publ)
Cost of Revenue Peer Comparison

Comparables:
O
OSSD
XVIVO
D
DOXA
BACTI B
V
VIMIAN

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
S2Medical AB (publ)
STO:S2M
Cost of Revenue
-kr1.1m
CAGR 3-Years
39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Cost of Revenue
-kr28.5m
CAGR 3-Years
-48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Cost of Revenue
-kr180.5m
CAGR 3-Years
-43%
CAGR 5-Years
-28%
CAGR 10-Years
-27%
D
Doxa AB
STO:DOXA
Cost of Revenue
-kr5.1m
CAGR 3-Years
23%
CAGR 5-Years
25%
CAGR 10-Years
12%
Bactiguard Holding AB
STO:BACTI B
Cost of Revenue
-kr161.9m
CAGR 3-Years
-24%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Cost of Revenue
-€182m
CAGR 3-Years
-64%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is S2Medical AB (publ)'s Cost of Revenue?
Cost of Revenue
-1.1m SEK

Based on the financial report for Jun 30, 2024, S2Medical AB (publ)'s Cost of Revenue amounts to -1.1m SEK.

What is S2Medical AB (publ)'s Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
39%

Over the last year, the Cost of Revenue growth was 9%. The average annual Cost of Revenue growth rates for S2Medical AB (publ) have been 39% over the past three years .

Back to Top